Akebia Therapeutics
AKBA
AKBA
130 hedge funds and large institutions have $360M invested in Akebia Therapeutics in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $423M → $360M (-$63M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 32
Holders
130
Holding in Top 10
2
Calls
$8.21M
Puts
$810K
Top Buyers
| 1 | +$9.88M | |
| 2 | +$8.97M | |
| 3 | +$4.38M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.01M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.28M |
Top Sellers
| 1 | -$28.2M | |
| 2 | -$20.6M | |
| 3 | -$3.67M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$3.44M |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$1.65M |